Skip to main content
SpringerLink
Log in

Factors Affecting Bioavailability and Efficacy of Topical Ophthalmic Preparations

  • Chapter
  • First Online:
Book cover Extemporaneous Ophthalmic Preparations

Abstract

There are several factors affecting the efficacy of topical ophthalmic preparations. Some factors are related to preparation technique while other factors are related to the structural and biochemical properties of the human eye [1–15].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. https://www.ashp.org/-/media/assets/policy-guidelines/docs/guidelines/pharmacy-prepared-ophthalmic-products.ashx.

  2. Baranowski P, Karolewicz B, Gajda M, Pluta J. Ophthalmic drug dosage forms: characterisation and research methods. Scientific World Journal. 2014;2014:861904. https://doi.org/10.1155/2014/861904, 14 pages.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Rathore S, Nema R, Sisodid S. An overview and advancement in ocular drug delivery systems. Int J Pharm Sci Res. 2010;1(10):11–23. Available from www.ijpsr.com. ISSN: 0975-8232

    CAS  Google Scholar 

  4. Patel A, Cholkar K, Agrahari V, Mitra A. Ocular drug delivery systems: an overview. World J Pharmacol. 2013;2(2):47–64. https://doi.org/10.5497/wjp.v2.i2.47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. McGhee PC. An overview of topical ophthalmic drugs and the therapeutics of ocular infection Professor. In: Ocular therapeutics; 2008. Available from Semantic Scholar.

    Google Scholar 

  6. Tangri P, Khurana S. Basics of ocular drug delivery systems. Int J Res Pharmaceut Biomed Sci. 2011;2(4):1541. ISSN: 2229-3701.

    Google Scholar 

  7. Patel PB, Shastri DH, Shelat PK, Shukla AK. Ophthalmic drug delivery system: challenges and approaches. Syst Rev Pharm. 2010;1(2):113.

    Article  CAS  Google Scholar 

  8. Kumar S, Bhowmik D, Paswan S, Srivastava S. Recent challenges and advances in ophthalmic drug delivery system. Pharm Innov J. 2012;1(4):1. Available from www.thepharmajournal.com. ISSN 2277-7695.

    Google Scholar 

  9. Morrison PW, Khutoryanskiy VV. Advances in ophthalmic drug delivery. Ther Deliv. 2014;5(12):1297–315.

    Article  CAS  PubMed  Google Scholar 

  10. Liang H, Brignole F, Rabinovich-Guilatt L, et al. Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions. Invest Ophthalmol Vis Sci. 2008;49(13):2357.

    Google Scholar 

  11. Evstigneev M, Evstigneev V, Santiago AH, Davies DB. Effect of a mixture of caffeine and nicotinamide on the solubility of vitamin (B 2) in aqueous solution. Eur J Pharm Sci. 2006;28(1):59–66.

    Article  CAS  PubMed  Google Scholar 

  12. Morrison PW, Connon CJ, Khutoryanskiy VV. Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability. Mol Pharm. 2013;10(2):756–62.

    Article  CAS  PubMed  Google Scholar 

  13. Coffman RE, Kildsig DO. Hydrotropic solubilization—mechanistic studies. Pharm Res. 1996;13(10):1460.

    Article  CAS  PubMed  Google Scholar 

  14. Ali Y, Lehmussaari K. Industrial perspective in ocular drug delivery. Adv Drug Deliv Rev. 2006;58(11):1258–68.

    Article  CAS  PubMed  Google Scholar 

  15. Rajasekaran A, Kumaran K, Preetha JP, Karthika K. A comparative review on conventional and advanced ocular drug delivery formulations. Int J PharmTech Res. 2010;2(1):668–74.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Senior Drug Safety Specialist, Pharmacovigilance Department, Saudi Food and Drug Authority, Riyadh, Saudi Arabia

    Eman Ali Saeed Alghamdi

  2. Consultant of Cornea, Cataract and Refractive Surgery, Ophthalmology Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia

    Abdulmalik Yahya Al Qahtani

  3. Senior Consultant Ophthalmic Surgeon, Dr. Mazen Sinjab Eye Clinic, Medcare Hospital, Dubai, United Arab Emirates

    Mazen M. Sinjab

  4. Consultant Clinical Pharmacist, Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia

    Khalid Mohammed Alyahya

Authors
  1. Eman Ali Saeed Alghamdi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abdulmalik Yahya Al Qahtani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mazen M. Sinjab
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Khalid Mohammed Alyahya
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Alghamdi, E.A.S., Al Qahtani, A.Y., Sinjab, M.M., Alyahya, K.M. (2020). Factors Affecting Bioavailability and Efficacy of Topical Ophthalmic Preparations. In: Extemporaneous Ophthalmic Preparations. Springer, Cham. https://doi.org/10.1007/978-3-030-27492-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27492-4_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27491-7

  • Online ISBN: 978-3-030-27492-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation